Why the OR Just Doesn’t Pay
Clinicians in virtually every medical and surgical specialty would have little trouble citing services for which they considered third-party reimbursement woefully inadequate for the time involved.
Commentary
Maximizing SWL Outcomes for Calculi
Urothiliasis afflicts 7%-13% of the population and has a recurrence rate of up to 50% at five years. In the United States, the economic burden of treatment and lost productivity was estimated at $2.1 billion in 2001.
“Good to Great” — Important Lessons in Medicine
While comparing summer “must read” lists, a friend suggested I pick up a copy of “Good to Great” (Jim Collins, Harper Collins 2001). My friend argued the premise of this book (that companies and indivi-duals who leap from “good to great” follow a consistent formula) has important implications in medicine.
Phosphate Binders Not the Whole Answer
Nephrologists and dietitians spend a significant amount of their time managing hyperphosphatemia. Phosphorus retention, which occurs in moderate to advanced CKD, is thought to contribute to secondary hyperparathyroidism and excessive vascular calcification.
Respect for the Placebo Effect
The placebo is an integral part of clinical research, helping investigators arrive at the true effect of an experimental treatment.
Targeted Therapies Include Targeted Surgery
The term “targeted therapy” has entered the oncologic lexicon over the past five years, with primary applications in medical and radiation oncology.
How to Control BP in Dialysis Patients
The characteristics of hypertension in hemodialysis patients differ from those in the general population. In dialysis patients, accelerated age-related changes in vascular stiffness, combined with factors peculiar to uremia, contribute to a loss of large and small vessel distensibility.
Meeting Size Doesn’t Matter
Renal & Urology News provides news coverage of about two dozen national and international meetings annually. Some of these meetings are a lot smaller than the annual meetings of the American Society of Nephrology and American Urological Society, but that does not mean we take them less seriously from a news standpoint.
New Surgical Options for BPH Must Measure Up
The past two decades have witnessed the introduction a dizzying array of minimally-invasive surgical alternatives to the gold standard treatments for BPH—transurethral resection of the prostate (TURP) and the open simple prostatectomy.
Anecdotes, Outcomes, and Evidence-Based Medicine
Go to a grand rounds or medical conference and listen. What do you hear? In most discussions of patient care, clinicians relate compelling anecdotes typically beginning with “I once had a patient who…” Fill in the blank.
- Loading...
Loading...
Next post in Commentary
Loading... 
Loading...